103441-60-7Relevant articles and documents
Practical Method for the Synthesis and Optical Resolution of Axially Dissymmetric 6,6'-Dimethylbiphenyl-2,2'-dicarboxylic Acid
Kanoh, Shigeyoshi,Muramoto, Hiroki,Kobayashi, Natsumi,Motoi, Masatoshi,Suda, Hiroshi
, p. 3659 - 3662 (1987)
Racemic 6,6'-dimethylbiphenyl-2,2'-dicarboxylic acid (1) could be conveniently synthesized and efficiently resolved by the recrystallization of the brucine salts in satisfactory yields.Each enantiomer, thus obtained, was confirmed to be optically pure from a high-performance liquid chromatographic (HPLC) analysis on an optically active column.
A significant improvement in enantioselectivity, yield, and reactivity for the copper-bi-o-tolyl bisoxazoline-catalyzed asymmetric allylic oxidation of cyclic olefins using recoverable SBA-15 mesoporous silica material
Samadi, Saadi,Nazari, Saber,Arvinnezhad, Hamid,Jadidi, Khosrow,Notash, Behrouz
, p. 6679 - 6686 (2013)
A series of chiral bi-o-tolyl bisoxazoline ligands 1 and 2 were conveniently synthesized on a gram scale from inexpensive and commercially available 3-methyl benzoic acid in eight steps. The catalytic and induced asymmetric effects of the chiral copper (I) complexes of these ligands on the asymmetric allylic oxidation of cycloolefins were investigated in the presence of various nano-sized additives. When SBA-15 mesoporous silica was used in conjunction with these ligands very highly enantioselectivities (up to 97% ee) and excellent yields (up to 99%) of the corresponding chiral allylic esters were obtained in a reasonably short period of time.
Divergent syntheses of iodinated isobenzofuranones and isochromenones by iodolactonization of 2-alkynylbenzoic acids in ionic liquids
Mancuso, Raffaella,Pomelli, Christian C.,Malafronte, Francesco,Maner, Asif,Marino, Nadia,Chiappe, Cinzia,Gabriele, Bartolo
supporting information, p. 4831 - 4841 (2017/07/10)
The regiochemical outcome of the iodolactonization of 2-alkynylbenzoic acids, carried out at 100 °C in ionic liquids (ILs) as unconventional solvents and with molecular iodine as the iodine source, in the absence of external bases, was found to be strongl
CHEMICAL COMPOUNDS
-
Page/Page column 36; 37, (2013/07/05)
The invention relates to a novel compound of formula (I) or a stereoisomer, or a racemate or a mixture or a pharmaceutically acceptable salt thereof: wherein: R is phenyl or a 5- or 6-membered heteroaryl ring containing 1 to 3 heteroatoms selected from S, N and O, such rings may be optionally substituted with n groups Q; Q is selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN, SO2CH3 or a group -O[(CR1R2]pQ1; or Q may be a group Q2; Q1 is phenyl, which may be optionally substituted with n substituents selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN, or a group Q2; or corresponds to 2,2-difluoro- benzo[d][1,3]dioxol-4-yl; Q2 is a 5- or 6-membered heteroaryl containing at least one nitrogen atom, which may optionally substituted with n substituents selected from a group consisting of: C1 C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN; P is a 6-membered heteroaryl or a 8-1 1 membered bicylic heteroaryl group, which may be substituted with n substituents selected from a group consisting of: C1-C4 alkyl, halogen, halo C1-C4 alkyl, C1-C4 alkoxy, CN; R1 is hydrogen or C1-C3 alkyl; R2 is hydrogen or C1-C3 alkyl; n is 1, 2 or 3; p is 0, 1 or 2; and with the proviso that when R corresponds to phenyl, P is substituted by at least one CF3; processes for the preparation of those compounds, pharmaceutical compositions containing one or more compounds of formula (I) and their use as dual antagonists of the Orexin 1 and Orexin 2 receptors.
